Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study - Wada, Naoki; Murakami, Takaaki; Fauzi, Muhammad; Sakaki, Kentaro; Oshima, Shinobu; Shimada, Yoshihito; Asai, Kanae; Oshima, Ayako; Nomura, Satoko; Joo, Erina; Mori, Michiko; Fujiwara, Ryoko; et al. (Journal of clinical medicine research, 2024)
Keywords: Short Communication; Imeglimin; GDF15; Diabetes mellitus